Doxazosin
Product Images NDC 33261-658

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 33261-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Doxazosin Mesylate 4mg Tab For Mylan 1)

Chemical structure of the active ingredient in Doxazosin by Aidarex Pharmaceuticals LLC, showing the molecular arrangement including a piperazine ring and dioxane fused to a quinazoline ring system with methoxy groups and an attached methanesulfonate group.*

FDA Label Image

Table 1 (Doxazosin Mesylate 4mg Tab For Mylan 2)

A data table and bar graph presenting clinical study results for Doxazosin from Aidarex Pharmaceuticals LLC. The table shows symptom score and maximum flow rate changes comparing placebo with Doxazosin at various doses, across three studies. The bar graph illustrates study 2 maximum flow rate changes at placebo, 4 mg, and 8 mg doses, highlighting statistically significant improvements with Doxazosin.*

FDA Label Image

Figure 1 (Doxazosin Mesylate 4mg Tab For Mylan 3)

Two line graphs from Study 1 comparing Doxazosin versus placebo over 14 weeks. The first graph shows the mean change in total symptom score from baseline, with Doxazosin demonstrating a greater decrease than placebo. The second graph depicts the mean increase in maximum urinary flow rate (mL/sec) from baseline, where Doxazosin shows a higher increase compared to placebo over the treatment duration.*

FDA Label Image

Image Label (Doxazosin Mesylate 4mg Tab For Mylan 4)

Label for Doxazosin 4 mg tablets by Aidarex Pharmaceuticals LLC. The label indicates 30 tablets per container and states it is a generic for Cardura. The active ingredient is doxazosin mesylate at 4 mg per tablet. Manufactured by Alphapharm Pty Ltd Australia, with NDC 33261-0658-30. The label includes dosage instruction fields and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.